HERBALIFE LTD. Restructuring Costs
HERBALIFE LTD. (HLF) reported Restructuring Costs of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-08-05
- HERBALIFE LTD. restructuring costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- HERBALIFE LTD. restructuring costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- HERBALIFE LTD. restructuring costs for the quarter ending 2025-12-31 was $2.20M, a 144.44% increase year-over-year.
- HERBALIFE LTD. restructuring costs for the quarter ending 2025-09-30 was $800.00K, a 70.37% decline year-over-year.
- HERBALIFE LTD. restructuring costs for fiscal 2025 was $7.00M, a 89.87% decline from fiscal 2024.
- HERBALIFE LTD. restructuring costs for fiscal 2024 was $69.10M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $2.20M derived: sum of 3 quarters · filed 2026-08-05 | $3.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $2.20M derived: sum of 2 quarters · filed 2026-05-06 | $3.00M derived: sum of 3 quarters · filed 2026-05-06 | $3.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $3.00M derived: sum of 2 quarters · filed 2026-02-18 | $3.70M derived: sum of 3 quarters · filed 2026-08-05 | $7.00M 10-K · filed 2026-02-18 |
| 2025-09-30 | $800.00K 10-Q · filed 2025-11-05 | $1.50M derived: sum of 2 quarters · filed 2026-08-05 | $4.80M 10-Q · filed 2025-11-05 | $5.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $700.00K 10-Q · filed 2026-08-05 | $4.00M 10-Q · filed 2026-08-05 | $4.90M derived: sum of 3 quarters · filed 2026-08-05 | $7.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $3.30M 10-Q · filed 2026-05-06 | $4.20M derived: sum of 2 quarters · filed 2026-05-06 | $6.90M derived: sum of 3 quarters · filed 2026-05-06 | $55.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $3.60M derived: sum of 2 quarters · filed 2026-02-18 | $52.40M derived: sum of 3 quarters · filed 2026-02-18 | $69.10M 10-K · filed 2026-02-18 |
| 2024-09-30 | $2.70M 10-Q · filed 2025-11-05 | $51.50M derived: sum of 2 quarters · filed 2025-11-05 | $68.20M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $48.80M 10-Q · filed 2025-08-06 | $65.50M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $16.70M 10-Q · filed 2025-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |